[1]
Potru, DO, FASAM, S., Sprintz, DO, DFASAM, M., Barreveld, MD, A.M. and Kohan, MD, L. 2021. Buprenorphine: Not a silver bullet, and still controversial. Journal of Opioid Management. 17, 7 (Aug. 2021), 9–10. DOI:https://doi.org/10.5055/jom.2021.0618.